Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
NEJM, 2022
With an appetite dysregulation, caloric intake is higher than it should be, which is causing a disruption and therefore excess body fat
Participants on all doses of Foundayo also experienced meaningful reductions in heart disease risk factors, Lilly said, including waist size, cholesterol and triglycerides levels, and blood pressure
She has to think carefully about everything she says
Each member brings a blend of medical knowledge, hands-on experience, and dedicated care to help you reach your medical weight loss goals